ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 149 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,767 | -8.1% | 43,086 | 0.0% | 0.00% | – |
| Q2 2023 | $69,368 | -35.3% | 43,086 | +16.5% | 0.00% | – |
| Q1 2023 | $107,280 | -11.6% | 36,993 | 0.0% | 0.00% | – |
| Q4 2022 | $121,337 | -13.7% | 36,993 | -0.6% | 0.00% | – |
| Q3 2022 | $140,639 | -51.4% | 37,206 | +0.1% | 0.00% | – |
| Q2 2022 | $289,624 | -11.9% | 37,179 | +5.1% | 0.00% | – |
| Q1 2022 | $328,662 | -52.4% | 35,378 | -19.2% | 0.00% | – |
| Q4 2021 | $690,000 | -11.1% | 43,789 | +1.0% | 0.00% | -100.0% |
| Q3 2021 | $776,000 | +7.2% | 43,352 | -6.9% | 0.00% | 0.0% |
| Q2 2021 | $724,000 | +11.6% | 46,576 | +3.1% | 0.00% | 0.0% |
| Q1 2021 | $649,000 | -26.2% | 45,173 | +0.8% | 0.00% | 0.0% |
| Q4 2020 | $880,000 | +65.1% | 44,818 | +9.1% | 0.00% | 0.0% |
| Q3 2020 | $533,000 | +12.0% | 41,092 | +19.4% | 0.00% | – |
| Q2 2020 | $476,000 | +68.2% | 34,408 | +3.4% | 0.00% | – |
| Q1 2020 | $283,000 | -44.4% | 33,284 | +7.6% | 0.00% | -100.0% |
| Q4 2019 | $509,000 | +21.5% | 30,930 | -0.6% | 0.00% | – |
| Q3 2019 | $419,000 | -24.8% | 31,129 | +12.3% | 0.00% | -100.0% |
| Q2 2019 | $557,000 | -48.7% | 27,713 | +1.5% | 0.00% | 0.0% |
| Q1 2019 | $1,085,000 | +22.2% | 27,301 | +6.8% | 0.00% | 0.0% |
| Q4 2018 | $888,000 | -21.1% | 25,557 | -6.1% | 0.00% | 0.0% |
| Q3 2018 | $1,126,000 | +2.3% | 27,225 | -9.2% | 0.00% | 0.0% |
| Q2 2018 | $1,101,000 | +15.3% | 29,969 | +22.3% | 0.00% | 0.0% |
| Q1 2018 | $955,000 | +144.2% | 24,505 | +13.3% | 0.00% | – |
| Q4 2017 | $391,000 | +16.0% | 21,624 | +6.5% | 0.00% | – |
| Q3 2017 | $337,000 | +18.2% | 20,298 | -0.4% | 0.00% | – |
| Q2 2017 | $285,000 | -27.1% | 20,377 | +7.2% | 0.00% | – |
| Q1 2017 | $391,000 | +67.1% | 19,008 | +15.5% | 0.00% | – |
| Q4 2016 | $234,000 | -33.5% | 16,456 | +0.1% | 0.00% | -100.0% |
| Q3 2016 | $352,000 | -4.9% | 16,435 | +0.1% | 0.00% | 0.0% |
| Q2 2016 | $370,000 | +69.7% | 16,420 | +41.7% | 0.00% | – |
| Q1 2016 | $218,000 | -27.3% | 11,587 | +2.0% | 0.00% | – |
| Q4 2015 | $300,000 | -15.0% | 11,365 | +1.3% | 0.00% | – |
| Q3 2015 | $353,000 | -30.1% | 11,219 | +17.1% | 0.00% | -100.0% |
| Q2 2015 | $505,000 | +343.0% | 9,583 | +249.6% | 0.00% | – |
| Q1 2015 | $114,000 | – | 2,741 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |